Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulfasalazine as an anti-fibrotic in acute alcoholic hepatitis
2006-004419-24Phase 4Unknown
- Sponsor
- University Hospital Southampton
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of 5-aminosalicylic acid + sulphasalazine in alcoholic hepatitis (AH), hepatic fibrosis and alcoholic liver disease (ALD), sponsored by University Hospital Southampton. Primary endpoint: Change in liver fibrosis score. Status: unknown.
02
Drugs
5-aminosalicylic acid + sulphasalazine
03
Conditions
alcoholic hepatitis (AH)hepatic fibrosisalcoholic liver disease (ALD)
Beyond the preview
Go deeper on 2006-004419-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004419-24.